1. 1. Jesse T Jacob, Eili Klein, Ramanan Laxminarayan, et al. Vital signs: carbapenem-resistant enterobacteriaceae. Morbidity and mortality weekly report 2013;62(9):165-70.
2. Doripenem;DL;Clinical infectious diseases,2009
3. Activities of doripenem (S-4661) against drug-resistant clinical pathogens;Jones;Antimicrobial agents and chemotherapy,2004
4. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations;Jones;The Journal of antimicrobial chemotherapy,2004
5. 5. Murray PR, Baron, EJ, Jorgensen JH, et al. Manual of clinical microbiology. Washington DC: ASM Press 2003;8th ed.